Your Health, We Care
Stiripentol is indicated for the treatment of seizures associated with Dravet syndrome (DS) in patients taking clobazam who are 6 months of age and older and weighing 7 kg or more. There are no clinical data to support the use of Stiripentol as monotherapy in Dravet syndrome.
from FDA，2022.07
Stiripentol is suitable for treating epileptic seizures associated with Dravet s···【more】
Release date：2026-01-05Recommended：11
Stiripentol significantly reduces generalized seizures by enhancing GABAergic ne···【more】
Release date：2024-08-29Recommended：255
Stiripentol is a drug that reduces seizures by modulating GABA receptors, especi···【more】
Release date：2024-08-28Recommended：255
Stiripentol was approved by the FDA in 2018 for significantly improving seizure ···【more】
Release date：2024-08-28Recommended：269
